Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets

Lung cancer is the leading cause of cancer deaths in both genders worldwide, with an incidence only second to prostate cancer in men and breast cancer in women. The lethality of the disease highlights the urgent need for innovative therapeutic options. Immunotherapy can afford efficient and specific...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Mirandola, Leonardo, Figueroa, Jose A., Phan, Tam T., Grizzi, Fabio, Kim, Minji, Rahman, Rakhshanda Layeequr, Jenkins, Marjorie R., Cobos, Everardo, Jumper, Cynthia, Alalawi, Raed, Chiriva-Internati, Maurizio
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413619/
https://ncbi.nlm.nih.gov/pubmed/25739119
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars